Tudor Investment Corp
FATE icon

Tudor Investment Corp’s Fate Therapeutics FATE Stock Holding History

Tudor Investment Corp’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48,169
Closed -$169K – 3161
2024
Q3 		$169K Buy
48,169
+2,879
+6% +$11.2K ﹤0.01% 2561
2024
Q2 		$149K Sell
45,290
-2,792
-6% -$12.2K ﹤0.01% 2183
2024
Q1 		$353K Buy
+48,082
New +$298K ﹤0.01% 1795
2023
Q4 		– Sell
-50,187
Closed -$106K – 2516
2023
Q3 		$106K Sell
50,187
-4,424
-8% -$14.7K ﹤0.01% 2146
2023
Q2 		$260K Buy
54,611
+2,177
+4% +$12K ﹤0.01% 2079
2023
Q1 		$299K Sell
52,434
-350
-0.7% -$2.11K ﹤0.01% 1935
2022
Q4 		$533K Buy
52,784
+5,785
+12% +$109K 0.01% 1540
2022
Q3 		$1.05M Buy
46,999
+10,284
+28% +$297K 0.02% 877
2022
Q2 		$910K Buy
36,715
+21,601
+143% +$596K 0.02% 946
2022
Q1 		$586K Sell
15,114
-18,401
-55% -$713K 0.01% 1181
2021
Q4 		$1.96M Buy
+33,515
New +$1.9M 0.03% 637
2021
Q2 		– Sell
-3,560
Closed -$294K – 1690
2021
Q1 		$294K Buy
+3,560
New +$341K 0.01% 1315
2020
Q4 		– Sell
-42,035
Closed -$1.68M – 1410
2020
Q3 		$1.68M Buy
42,035
+4,325
+11% +$151K 0.07% 363
2020
Q2 		$1.29M Buy
+37,710
New +$1.12M 0.06% 396
2019
Q4 		– Sell
-46,484
Closed -$722K – 1213
2019
Q3 		$722K Buy
+46,484
New +$891K 0.02% 599

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Tudor Investment Corp's FATE Position: Q4 2024 in Review

Tudor Investment Corp sold out of Fate Therapeutics (FATE) in Q4 2024, closing a stake of 48,169 shares — an estimated $169K sold.

Tudor Investment Corp first reported a position in FATE in Q3 2019 and held it in 15 quarters. The position peaked at $1.96M in Q4 2021. 159 funds tracked by Wall St. Rank hold FATE as of Q4 2024.

  • Tudor Investment Corp reported no remaining Fate Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 48,169 Fate Therapeutics shares in Q4 2024, an estimated $169K.
  • Tudor Investment Corp first reported a position in Fate Therapeutics in Q3 2019 and held it in 15 quarters.
  • Tudor Investment Corp's Fate Therapeutics position peaked at $1.96M in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.